TrialBMC gastroenterology2013

Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.

Hubert Mönnikes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.